HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seroprevalence of Trypanosoma cruzi in kidney transplant donors and recipients in Mexico City.

Abstract
Infectious diseases are common causes of morbidity and mortality among kidney transplant recipients. Chagas disease (CD) has been recognized as an emerging infectious complication of transplantation caused by the parasite Trypanosoma cruzi. CD is prevalent in Mexico, particularly in the southern coastal region. The impact on Mexican kidney transplant programs has not been previously studied prospectively. From 2009 through 2010, serum samples from 59 kidney transplant donors and 405 renal transplant recipients were screened for antibodies against T. cruzi. Serum was initially screened using a locally developed ELISA test; positive results were confirmed by an indirect immunofluorescense test, in accordance with Panamerican Health Organization/World Health Organization guidelines. None of the donors were seropositive for T. cruzi, while 8 (1.97%) kidney transplant recipients were confirmed to be seropositive for T. cruzi. None of them have developed clinical manifestations of CD, although specific screening of recipients was not performed. A prospective study is planned to define the epidemiology and outcome of CD among kidney transplant donors and recipients in Mexico more thoroughly.
AuthorsR Rodríguez-Romo, L E Morales-Buenrostro, P A Reyes, C Gracida, M Medeiros, E Mancilla, C De Leo, J Alberú
JournalTransplant infectious disease : an official journal of the Transplantation Society (Transpl Infect Dis) Vol. 15 Issue 6 Pg. 639-44 (Dec 2013) ISSN: 1399-3062 [Electronic] Denmark
PMID23901935 (Publication Type: Journal Article)
Copyright© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Chemical References
  • Antibodies, Protozoan
Topics
  • Adolescent
  • Adult
  • Antibodies, Protozoan (blood)
  • Chagas Disease (blood, epidemiology)
  • Child
  • Female
  • Humans
  • Kidney Transplantation
  • Male
  • Mexico (epidemiology)
  • Middle Aged
  • Prevalence
  • Prospective Studies
  • Seroepidemiologic Studies
  • Trypanosoma cruzi (immunology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: